Skip to main content
Share
Print this page
Email this page link to a friend
FaceBook
Tweet this
Photo of Song Zhao

Song Zhao, MD, PhD

Languages: English, Chinese - Mandarin
Specialties:
Accepting New Patients
Professional Statement
To provide the best cancer care through multidisciplinary, evidence-based — yet personalized — approaches.
Education
Institution
Type
Field of Study
Peking Union Medical College, Beijing, China
Medical School
North Shore University Hospital
Residency
Internal Medicine
University of Washington School of Medicine
Fellowship
Oncology/Hematology
Memorial Sloan-Kettering Cancer Center, New York
Postdoctoral Research
University of Texas Health Science Center at San Antonio
Graduate School
Molecular Medicine
Personal Interests
Dr Zhao enjoys spending time with my family, hiking, camping and playing soccer.
Board Certifications
  • American Board of Internal Medicine, Internal Medicine
Services
Clinical Interests
  • amyloidosis
  • anemia
  • b12 deficiency anemia
  • bladder cancer
  • cancer
  • cancer chemotherapy
  • cancer during pregnancy
  • cancer survivorship
  • egfr mutation
  • endocrine complications of cancer therapy
  • hellp syndrome
  • hemolytic uremic syndrome
  • heparin induced thrombocytopenia
  • hereditary spherocytosis
  • histiocytosis
  • idiopathic thrombocytopenic purpura
  • iron deficiency anemia
  • leukopenia
  • malignant neoplasm of prostate
  • maternal hematologic disorders
  • myelodysplasia
  • myelodysplastic syndrome
  • neutropenia
  • pancytopenia
  • plasma cell dyscrasia
  • polycythemia
  • pulmonary metastases
  • renal cancer
  • rh incompatibility
  • secondary polycythemia
  • teratogen exposure
  • testicular cancer
  • thalassemia
  • thrombocytopenia
  • thrombophilia
  • thrombotic thrombocytopenic purpura
  • unknown primary cancer
Publications
Zhang SQ, Zhao S, Min JM, Wang K, Liu SL, Zheng D.X. (1998) Z-ajoene induces tumor cell death by apoptosis. Chin. Sci. Bulletin, 43: 961-965.

Dasika GK, Lin SC, Zhao S, Sung P, Tomkinson A, Lee E.Y.-H. P. (1999) DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis. Oncogene, 18:7883-7899.

Zhao S, Weng YC, Yuan SS, Lin YT, Hsu HC, Lin SC, Gerbino E, Song MH, Zdzienicka MZ, Gatti RA, Shay JW, Ziv Y, Shiloh Y, Lee E.Y.-H. P. (2000) Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products. Nature, 405: 473-477.

Yazdi PT, Wang Y, Zhao S, Patel N, Lee E.Y.-H.P., Qin J. (2002) SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint. Genes & Development, 16(5): 571-582.

Yuan SS, Su JH, Hou MF, Yang FW, Zhao S, Lee E.Y.-H. P. (2002) Arsenic-induced Mre11 phosphorylation is cell cycle-dependent and defective in NBS cells. DNA Repair, 1(2): 137-142.

Zhao S, Renthal W, Lee E.Y.-H. P. (2002) Functional Analysis of FHA and BRCT domains of NBS1 in chromatin association and DNA damage responses. Nucleic Acids Research, 30(22): 4815-4822.

Lee F, Harris WP, Cheng HH, Shenoi J, Zhao S, Wang J, Champion T, Izard J, Gore JL, Porter MP, Yu EY, Wright J.L. (2013) Pathologic Response Rates of Gemcitabine/Cisplatin Vs. Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer. Advances in Urology, 2013: 317190.

Mossanen M, Lee F, Cheng HH, Harris W, Shenoi J, Zhao S, Wang J, Champion T, Izard J, Gore JL, Porter MP, Yu EY, Wright J.L. (2014) Nonresponse to Neoadjuvant Chemotherapy for Muscle-Invasive Urothelial Cell Carcinoma of the Bladder. Clin Genitourin Cancer. 12(3): 210-213.

Zhao S and Yu E.Y. (2013) Castrate Resistant Prostate Cancer: Post-Docetaxel Management. Current Opinions in Urology, 23(3): 201-207.

Zhao S and Nelson P.S. (2013) Leveraging the Species Barrier to Advance Cancer Therapy. Nature Genetics, 45(7):718-20.

James AC, Lee F, Harris WP, Cheng HH, Zhao S, Gore JL, Lin DW, Porter MP, Yu EY, Wright J.L. (2014) Role of Maximal Endoscopic Resection Before Cystectomy for Invasive Urothelial Bladder Cancer. Clinical Genitourinary Cancer. 12(4): 287-291.

Huber RM, Lucas JM, Gomez-Sarosi LA, Coleman I, Zhao S, Coleman R, Nelson P.S. (2015) DNA damage induces GDNF secretion in the tumor microenvironment with paracrine effects promoting prostate cancer treatment resistance. Oncotarget. 6(4): 2134-2147.

ABSTRACTS

Zhao S, Coleman I, Coleman R, and Nelson P.S. (2013) PARP inhibitors attenuate docetaxel resistance by suppressing a tumor microenvironment-associated secretory program (abstract# e22212). American Society of Clinical Oncology Annual Meeting 2013.

James AC, Lee F, Harris WP, Cheng HH, Zhao S, Gore JL, Lin DW, Porter MP, Yu EY, Wright J.L. Role of maximal endoscopic resection prior to cystectomy for invasive urothelial bladder cancer (2013) American Urologic Association Annual Meeting; San Diego, CA 2013

Mossanen M, Lee F, Cheng H, Harris W, Shenoi J, Zhao S, Wang J, Champion T, Izard J, Gore J, Porter M, Yu E, and Wright J. Non-Response to Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Cell Carcinoma of the Bladder (2013) American Urologic Association Annual Meeting; San Diego, CA 2013
1346562816
 
Office of Dr. Zhao and Dr. Goldberg
1221 Madison Street Suite 1020
Seattle, WA 98104
206-386-9501
206-386-9547
Affiliated Facilities
Swedish Issaquah
Swedish Cherry Hill
Swedish First Hill